OmniActive Health Technologies (Bridgewater, NJ and Mumbai, India) announced its collaboration with the Council of Responsible Nutrition (CRN) to highlight the significance of lutein and zeaxanthin isomers for prenatal nutrition at The American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical & Scientific Meeting, which will take place May 17-19 in San Francisco, CA.
OmniActive is one of six companies involved in the partnership alongside Balchem, Church & Dwight Co., dsm-firmenich, Kemin Human Nutrition and Health and Pharmavite. The partnership aims to educate and elevate awareness among obstetricians and gynecologists, and other maternal health care practitioners about the pivotal role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy. This initiative underscores OmniActive and CRN’s commitment to advancing the understanding of nutritional requirements during pregnancy and ensuring the availability of scientifically validated products to meet these needs.
“It’s wonderful to have OmniActive as one of our featured partners during the ACOG annual event to help spread the word on the importance of prenatal nutrition,” said Dr. Andrea Wong, CRN’s senior vice president, scientific & regulatory affairs. “CRN continues our efforts in supporting supplement manufacturers and ingredient suppliers in bringing clinically studied products to consumers to help meet their nutritional needs. Advancing awareness at the physician’s level is a huge part of this equation and this meeting is an effective way of reaching them.”
In the U.S., prenatal vitamins and supplements sales are expected to have exponential growth in the coming years, with estimates of $740 million in 2023 rising to $1.43 billion by 2031, according to SkyQuest Technology. This growth is indicative of an increasing awareness of the importance of nutrition and supplementation during pregnancy. Moreover, a recent study showed that roughly 60 percent of gynecologists believe that 80-100 percent of their patients take supplements during pregnancy. As research around the nutritional needs in pregnancy expands, so will the need to bring products that deliver efficacious levels of certain nutrients, such as lutein and zeaxanthin, to the market.
“Current evidence supports the preferential accumulation of lutein and zeaxanthin in the human eye and neural tissues during pregnancy, especially during the third trimester. This suggests that lutein may play a functional and protective role in infant visual and cognitive development. As part of our Lutein For Every Age campaign, our goal is to help educate health care practitioners on this latest nutritional science research and the benefits of achieving adequate dietary lutein during pregnancy,” said Deshanie Rai, PhD, FACN, vice president of global science, regulatory and advocacy at OmniActive Health Technologies. “OmniActive is proud to partner with the CRN Foundation’s Prenatal Nutrition Centre to promote awareness among health care practitioners on the nutritional relevance of lutein for both mom and baby.”
“Lutein for Every Age” is an educational initiative, which focuses on raising awareness of early and consistent lutein and zeaxanthin intake to help support eye, cognitive and general health throughout life. Through various media, digital platforms, in-person events, scientific advocacy, and key opinion leaders, OmniActive remains committed to educating consumers and health care practitioners on the importance of these essential nutrients.
For more information, visit www.lutemax.com/lfea.
